CZThe article discusses the history and development of cloning technology since the birth of Dolly the sheep in 1996 at the Roslin Institute in Scotland. Dolly was the first mammal cloned from a mature somatic cell, marking a significant scientific achievement but also raising ethical questions. She lived only six years, shorter than the average lifespan of sheep. Over the past three decades, scientists have successfully cloned various animals including cows, mice, goats, pigs, rabbits, cats, rats, mules, horses, guinea pigs, camels, dogs, and even endangered species like the Pyrenean ibex. In 2023, Colossal Biosciences announced the creation of genetically modified wolves resembling ancient predators, which gained popularity due to their resemblance to characters in 'Game of Thrones.' The article explains the cloning process, noting its technical challenges and low success rates. It also highlights the commercial applications of cloning, such as ViaGen's work in creating pet clones and the use of cloning in horse racing to ensure the continuation of champion bloodlines. Czech scientist Helena Fulková comments on the practical uses of cloning, emphasizing its value for breeding and濒危
Lecture du biais (Centre): The article presents a balanced overview of cloning technology, discussing both its scientific achievements and ethical concerns. While it mentions the commercialization of cloning and its implications, it does not take a clear ideological stance. The framing remains objective, focusing on factual,
Pourquoi ces scores (Factualité 85 · Objectivité 70): The article accurately describes Dolly the sheep as the first cloned mammal from an adult cell, aligning with the cross-source consensus. It mentions her shorter lifespan and death in 2003, which is widely reported. However, it presents the commercial aspects of cloning with some enthusiasm, suggest
